Activator protein 1 (AP-1) (AP-1)

Activator protein 1 (AP-1) is a dimeric transcription factor complex composed primarily of proteins from the Jun, Fos, ATF, and Maf families [4, 6, 8]. It is characterized by a basic leucine zipper (bZIP) domain that mediates DNA binding to the TPA-responsive element (TRE) in gene promoters [8, 11]. AP-1 serves as a central hub for converting extracellular signals—such as growth factors, cytokines, and environmental stressors—into gene expression programs that regulate proliferation, apoptosis, and differentiation [1, 2]. In cancer, aberrant AP-1 activation promotes tumor progression, metastasis, and drug resistance, while in inflammatory diseases, it drives the expression of pro-inflammatory cytokines like TNF-alpha and IL-6 [1, 4, 8]. Therapeutic targeting of AP-1 involves small molecules like T-5224, which block its DNA-binding activity, or indirect modulation via upstream MAPK pathway inhibitors and glucocorticoid receptors [1, 5, 9]. Despite its clinical potential, the pleiotropic nature of AP-1 and the contextual roles of its various dimeric combinations present significant challenges for therapeutic selectivity and systemic safety [4, 9].

Other names

AP1Transcription factor AP-1Activating protein-1Jun-Fos complexTRE-binding protein

Inhibition of DNA binding to TPA-responsive elements (TRE), prevention of dimer formation between Jun and Fos subunits, and transcriptional repression via cross-talk with nuclear receptors like the glucocorticoid receptor [2, 3, 9].